Course contents

AcneTest - Scientific Background and Clinical Interpretation

Prescribers
Pharmacists

Genetics, Dermatology

This course explores a personalized approach to acne management through the integration of genetic testing and targeted therapeutic strategies. Participants will gain a deeper understanding of acne pathophysiology, including sebum production, inflammation, keratinization, and bacterial involvement, as well as the limitations of conventional “trial-and-error” treatments.

The course introduces AcneTest, a genetic test designed to identify individual variations that influence acne development and response to treatment. Learners will explore how specific genetic markers can guide the selection of active ingredients, enabling more precise and effective formulations tailored to each patient. Key pathways such as androgen activity, inflammatory response, oxidative stress, and skin barrier function are analyzed to support evidence-based decision-making. Through practical examples and case-based insights, participants will learn how to interpret AcneTest reports and translate them into personalized treatment plans, optimizing outcomes and improving patient adherence.
 English only
  Prescribers (target audience), Pharmacists
Write your awesome label here.
Write your awesome label here.
Compounding tips? Visit our

Formulary
A global hub for compounding knowledge and formulation guidance.

Adapalene 0.1% and Benzoyl Peroxide 1.0% in Cleoderm™

Topical cream

Dapsone 5% to 10% in Cleoderm™

Topical cream

Clindamycin 1% and Salicylic Acid 2%

Topical solution

Why should I take this course?

  • Understand the genetic and biological mechanisms underlying acne and treatment variability
  • Learn how to use AcneTest to guide personalized therapy and ingredient selection
  • Improve clinical outcomes by moving from trial-and-error to targeted, evidence-based acne management

Course Lessons

Meet your instructor

Dr. Bruna Bravo

Dr. Bruna Félix Bravo is a dermatologist and academic with extensive experience in clinical practice, research, and medical education. She currently serves as Coordinator of the Cosmiatry Department of the Brazilian Society of Dermatology – Rio de Janeiro (SBD-RJ) for the 2025–2026 term. She is board-certified in Dermatology by the Brazilian Society of Dermatology (SBD) and is a member of the Brazilian Society of Dermatologic Surgery (SBCD). Dr. Bravo holds a Master’s degree in Medicine from the Federal University of Rio de Janeiro (UFRJ) and is currently a PhD candidate at the State University of Rio de Janeiro (UERJ). Her academic training includes postgraduate studies at Harvard Medical School, where she completed programs in clinical research methods and medical education. She is the author of more than 50 scientific publications and book chapters in dermatology. In addition to her academic and clinical work, Dr. Bravo serves as a medical consultant for leading pharmaceutical and dermocosmetic companies, including Allergan, Merz, Galderma, Rennova, Croma, L’Oréal, Bioderma, Avène, and Entera.

Enjoyed this content? You may also like these ones: